Literature DB >> 12088204

Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.

Patrizia Bossolasco1, Clara Ricci, Gabriella Farina, Davide Soligo, Donata Pedretti, Alberto Scanni, Giorgio Lambertenghi Deliliers.   

Abstract

The detection of circulating cancer cells in the bone marrow (BM) and peripheral blood (PB) of patients with solid tumors may be useful for disease staging. To this aim, we evaluated the expression of the mammaglobin gene by reverse transcriptase polymerase chain reaction (RT-PCR) in 60 patients with breast cancer. Moreover, several controls were examined to test the specificity of this marker. The positive cases included 23.6% of the patients with and 9% of those without metastasis. Only 4/60 negative controls analyzed were positive by PCR. Our results show high specificity and a good correlation with disease status.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088204     DOI: 10.1016/s0361-090x(02)00009-0

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  14 in total

Review 1.  The detection of circulating breast cancer cells in blood.

Authors:  A M Gilbey; D Burnett; R E Coleman; I Holen
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

2.  Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation.

Authors:  Ningfang Wang; Lan Shi; Huiyu Li; Yanjie Hu; Wen Du; Wei Liu; Jin'e Zheng; Shiang Huang; Xincai Qu
Journal:  Tumour Biol       Date:  2012-01-13

3.  Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.

Authors:  Barbara K Zehentner; David H Persing; Amadou Deme; Papa Toure; Stephen E Hawes; Lisa Brooks; Qinghua Feng; Dawn C Hayes; Cathy W Critichlow; Raymond L Houghton; Nancy B Kiviat
Journal:  Clin Chem       Date:  2004-09-16       Impact factor: 8.327

4.  Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.

Authors:  Chidananda M Siddappa; Mark A Watson; Sreeraj G Pillai; Kathryn Trinkaus; Timothy Fleming; Rebecca Aft
Journal:  Breast Cancer Res Treat       Date:  2012-11-06       Impact factor: 4.872

Review 5.  Integrating circulating tumor cell assays into the management of breast cancer.

Authors:  Shaheenah Dawood; Massimo Cristofanilli
Journal:  Curr Treat Options Oncol       Date:  2007-02

6.  A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.

Authors:  Nadia Saucedo-Zeni; Steffi Mewes; Robert Niestroj; Lukasz Gasiorowski; David Murawa; Piotr Nowaczyk; Tatiana Tomasi; Ekkehard Weber; Grzegorz Dworacki; Nils G Morgenthaler; Heike Jansen; Corinna Propping; Karolina Sterzynska; Wojciech Dyszkiewicz; Maciej Zabel; Marion Kiechle; Ute Reuning; Manfred Schmitt; Klaus Lücke
Journal:  Int J Oncol       Date:  2012-07-16       Impact factor: 5.650

7.  Circulating and disseminated tumor cells in the management of advanced prostate cancer.

Authors:  Stephan Kruck; Georgios Gakis; Arnulf Stenzl
Journal:  Adv Urol       Date:  2011-08-21

8.  Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients.

Authors:  Sabine Riethdorf; Klaus Pantel
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

9.  Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.

Authors:  Alison L Allan; Michael Keeney
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

Review 10.  Detecting circulating tumor cells: current challenges and new trends.

Authors:  Bin Hong; Youli Zu
Journal:  Theranostics       Date:  2013-04-23       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.